A citation-based method for searching scientific literature

Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
Times Cited: 80



Mingzhao Xing. Nat Rev Cancer 2013
Times Cited: 785




List of shared articles



Times cited


CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis.
Shi-Tong Yu, Bai-Hui Sun, Jun-Na Ge, Jiao-Long Shi, Man-Sheng Zhu, Zhi-Gang Wei, Ting-Ting Li, Zhi-Cheng Zhang, Wei-Sheng Chen, Shang-Tong Lei. Front Endocrinol (Lausanne) 2020
4

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
Jierui Liu, Yanqing Liu, Yansong Lin, Jun Liang. Endocrinol Metab (Seoul) 2019
15

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou. NPJ Precis Oncol 2021
2

TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
Jie Tan, Rengyun Liu, Guangwu Zhu, Christopher B Umbricht, Mingzhao Xing. Proc Natl Acad Sci U S A 2020
9


BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
Fei Wang, Shihua Zhao, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo,[...]. J Clin Oncol 2018
26

Novel Targeted Therapies for Metastatic Thyroid Cancer-A Comprehensive Review.
Mohammad Al-Jundi, Shilpa Thakur, Sriram Gubbi, Joanna Klubo-Gwiezdzinska. Cancers (Basel) 2020
9

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma.
Huajing Teng, Fengbiao Mao, Jialong Liang, Meiying Xue, Wenqing Wei, Xianfeng Li, Kun Zhang, Dongdong Feng, Baoguo Liu, Zhongsheng Sun. Theranostics 2018
31


Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18